Omar N. Al Safarjalani

Author

University of Alabama at Birmingham

Also Known As

Omar N Al Safarjalani, Omar N. Al Safarjalani, Omar N. Safarjalani

Publications

474

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham University of Georgia Emory University Veterans Health Administration Performance Communications

About

Omar N. Al Safarjalani is an author at University of Alabama at Birmingham specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	303
2	Biochemistry	4	4	103
3	Chemical Biology	4	4	88
4	Biomolecular Engineering	3	3	77
5	Natural Sciences	2	2	48

Omar N. Al Safarjalani

Publications

463

Citations

H-Index

Page 1

	Year	Citations
5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens Omar N. Al Safarjalani, Xiao‐Jian Zhou, Reem H. Rais, Cancer Chemotherapy and Pharmacology Medicinal ChemistryUrologyPharmaceutical ScienceMedicineOral Uridine Bioavailability	2005	68
Synthesis, Biological Activity and Molecular Modeling of 6-Benzylthioinosine Analogues as Subversive Substrates of<i>Toxoplasma</i><i>g</i><i>ondii</i>Adenosine Kinase Vikas Yadav, Chung K. Chu, Reem H. Rais, Journal of Medicinal Chemistry	2004	49
Metabolism and Selective Toxicity of 6-Nitrobenzylthioinosine in <i>Toxoplasma gondii</i> Mahmoud H. el Kouni, Vincenzo Guarcello, Omar N. Al Safarjalani, Antimicrobial Agents and Chemotherapy	1999	43
Structure−Activity Relationships of 7-Deaza-6-benzylthioinosine Analogues as Ligands of<i>Toxoplasma gondii</i>Adenosine Kinase Young Ah Kim, Ashoke Sharon, Chung K. Chu, Journal of Medicinal Chemistry	2008	37
Uridine phosphorylase inhibitors: Chemical modification of benzyloxybenzyl-barbituric acid and its effects on UrdPase inhibition David Guérin, Daniel Mazéas, Manoj S. Musale, Bioorganic & Medicinal Chemistry Letters Pharmaceutical ChemistryBiochemistryMedicineChemical ModificationUrdpase Inhibition	1999	37
Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents Young Ah Kim, Ashoke Sharon, Chung K. Chu, Biochemical Pharmacology Combinatorial ChemistryBioorganic ChemistryBiochemistryN6-benzyladenosine AnaloguesPotential Anti-toxoplasma Agents	2007	36
7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities Omar N. Al Safarjalani, Reem H. Rais, Young Ah Kim, Biochemical Pharmacology Selective Toxicities7-Deaza-6-benzylthioinosine AnaloguesMedicineAdenosine KinaseReceptor Tyrosine Kinase	2008	35
Uptake of Nitrobenzylthioinosine and Purine β- <scp>l</scp> -Nucleosides by Intracellular <i>Toxoplasma gondii</i> Omar N. Al Safarjalani, Fardos N.M. Naguib, Mahmoud H. el Kouni Antimicrobial Agents and Chemotherapy	2003	31
6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities Reem H. Rais, Omar N. Al Safarjalani, Vikas Yadav, Biochemical Pharmacology MedicineDrug DiscoveryAdenosine KinaseCell Death6-Benzylthioinosine Analogues	2005	25
Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor Omar N. Al Safarjalani, Reem H. Rais, Junxing Shi, Cancer Chemotherapy and Pharmacology Chemoprevention StrategyMedicineUridine Phosphorylase InhibitorPharmacologyHuman Colon Tumors	2006	19

Page 1